Globe Life (GL)
Market Price (3/3/2026): $146.35 | Market Cap: $11.6 BilSector: Financials | Industry: Life & Health Insurance
Globe Life (GL)
Market Price (3/3/2026): $146.35Market Cap: $11.6 BilSector: FinancialsIndustry: Life & Health Insurance
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.5%, FCF Yield is 11% | Trading close to highsDist 52W High is -0.4%, Dist 3Y High is -0.4% | Short seller reportFuzzy Panda Research report on 4/11/2024. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -133% | Weak multi-year price returns2Y Excs Rtn is -19%, 3Y Excs Rtn is -47% | Key risksGL key risks include [1] a Department of Justice probe and class action lawsuits over allegations of widespread fraud at its AIL subsidiary, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 21% | ||
| Low stock price volatilityVol 12M is 26% | ||
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Fintech & Digital Payments, and AI in Financial Services. Themes include Geriatric Care, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.5%, FCF Yield is 11% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -133% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 21% |
| Low stock price volatilityVol 12M is 26% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Fintech & Digital Payments, and AI in Financial Services. Themes include Geriatric Care, Show more. |
| Trading close to highsDist 52W High is -0.4%, Dist 3Y High is -0.4% |
| Weak multi-year price returns2Y Excs Rtn is -19%, 3Y Excs Rtn is -47% |
| Short seller reportFuzzy Panda Research report on 4/11/2024. |
| Key risksGL key risks include [1] a Department of Justice probe and class action lawsuits over allegations of widespread fraud at its AIL subsidiary, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Globe Life (GL) stock has gained about 10% since 11/30/2025 because of the following key factors:
1. Robust Earnings and Elevated 2026 Guidance.
Globe Life reported strong financial results for the fourth quarter of 2025, with net operating income increasing 8% year-over-year to $3.39 per diluted common share. The full-year 2025 net operating EPS of $14.52 surpassed the midpoint of the company's previous guidance. Management further boosted investor confidence by raising its full-year 2026 net operating income guidance to a range of $14.95 to $15.65 per diluted share, representing an approximate 10% normalized EPS growth. This positive performance was particularly driven by the United American Division, which saw health net sales surge by 155% to approximately $77 million over the year-ago quarter.
2. Shareholder Value Through Significant Share Repurchases.
The company demonstrated a commitment to returning capital to shareholders through substantial share repurchases. In the fourth quarter of 2025, Globe Life repurchased approximately 1.3 million shares of its common stock, totaling about $170 million. For the entire year ended December 31, 2025, the company bought back 5.4 million shares at a total cost of $685 million.
Show more
1. Robust Earnings and Elevated 2026 Guidance.
Globe Life reported strong financial results for the fourth quarter of 2025, with net operating income increasing 8% year-over-year to $3.39 per diluted common share. The full-year 2025 net operating EPS of $14.52 surpassed the midpoint of the company's previous guidance. Management further boosted investor confidence by raising its full-year 2026 net operating income guidance to a range of $14.95 to $15.65 per diluted share, representing an approximate 10% normalized EPS growth. This positive performance was particularly driven by the United American Division, which saw health net sales surge by 155% to approximately $77 million over the year-ago quarter.
2. Shareholder Value Through Significant Share Repurchases.
The company demonstrated a commitment to returning capital to shareholders through substantial share repurchases. In the fourth quarter of 2025, Globe Life repurchased approximately 1.3 million shares of its common stock, totaling about $170 million. For the entire year ended December 31, 2025, the company bought back 5.4 million shares at a total cost of $685 million.
Show more
Stock Movement Drivers
Fundamental Drivers
The 8.8% change in GL stock from 11/30/2025 to 3/2/2026 was primarily driven by a 6.1% change in the company's P/E Multiple.| (LTM values as of) | 11302025 | 3022026 | Change |
|---|---|---|---|
| Stock Price ($) | 134.47 | 146.33 | 8.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5,941 | 5,994 | 0.9% |
| Net Income Margin (%) | 19.4% | 19.4% | 0.0% |
| P/E Multiple | 9.4 | 10.0 | 6.1% |
| Shares Outstanding (Mil) | 81 | 79 | 1.6% |
| Cumulative Contribution | 8.8% |
Market Drivers
11/30/2025 to 3/2/2026| Return | Correlation | |
|---|---|---|
| GL | 8.8% | |
| Market (SPY) | 0.4% | 14.3% |
| Sector (XLF) | -3.8% | 43.2% |
Fundamental Drivers
The 5.0% change in GL stock from 8/31/2025 to 3/2/2026 was primarily driven by a 7.0% change in the company's Net Income Margin (%).| (LTM values as of) | 8312025 | 3022026 | Change |
|---|---|---|---|
| Stock Price ($) | 139.41 | 146.33 | 5.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5,883 | 5,994 | 1.9% |
| Net Income Margin (%) | 18.1% | 19.4% | 7.0% |
| P/E Multiple | 10.7 | 10.0 | -6.6% |
| Shares Outstanding (Mil) | 82 | 79 | 3.1% |
| Cumulative Contribution | 5.0% |
Market Drivers
8/31/2025 to 3/2/2026| Return | Correlation | |
|---|---|---|
| GL | 5.0% | |
| Market (SPY) | 6.7% | 16.7% |
| Sector (XLF) | -4.7% | 50.1% |
Fundamental Drivers
The 15.8% change in GL stock from 2/28/2025 to 3/2/2026 was primarily driven by a 5.7% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 2282025 | 3022026 | Change |
|---|---|---|---|
| Stock Price ($) | 126.39 | 146.33 | 15.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5,778 | 5,994 | 3.7% |
| Net Income Margin (%) | 18.5% | 19.4% | 4.5% |
| P/E Multiple | 9.9 | 10.0 | 1.0% |
| Shares Outstanding (Mil) | 84 | 79 | 5.7% |
| Cumulative Contribution | 15.8% |
Market Drivers
2/28/2025 to 3/2/2026| Return | Correlation | |
|---|---|---|
| GL | 15.8% | |
| Market (SPY) | 16.5% | 55.1% |
| Sector (XLF) | -0.7% | 67.8% |
Fundamental Drivers
The 23.4% change in GL stock from 2/28/2023 to 3/2/2026 was primarily driven by a 22.1% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 2282023 | 3022026 | Change |
|---|---|---|---|
| Stock Price ($) | 118.60 | 146.33 | 23.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 5,227 | 5,994 | 14.7% |
| Net Income Margin (%) | 17.1% | 19.4% | 13.2% |
| P/E Multiple | 12.9 | 10.0 | -22.1% |
| Shares Outstanding (Mil) | 97 | 79 | 22.1% |
| Cumulative Contribution | 23.4% |
Market Drivers
2/28/2023 to 3/2/2026| Return | Correlation | |
|---|---|---|
| GL | 23.4% | |
| Market (SPY) | 79.7% | 22.0% |
| Sector (XLF) | 50.2% | 35.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| GL Return | -0% | 30% | 2% | -8% | 26% | 4% | 60% |
| Peers Return | 22% | 8% | 20% | 38% | 16% | -6% | 136% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 0% | 83% |
Monthly Win Rates [3] | |||||||
| GL Win Rate | 58% | 50% | 50% | 67% | 67% | 67% | |
| Peers Win Rate | 68% | 47% | 60% | 63% | 63% | 20% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| GL Max Drawdown | -9% | -5% | -14% | -59% | -0% | -2% | |
| Peers Max Drawdown | -5% | -24% | -14% | -4% | -6% | -8% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AFL, CNO, UNM, PRI, LNC. See GL Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/2/2026 (YTD)
How Low Can It Go
| Event | GL | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -19.9% | -25.4% |
| % Gain to Breakeven | 24.9% | 34.1% |
| Time to Breakeven | 307 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -47.7% | -33.9% |
| % Gain to Breakeven | 91.2% | 51.3% |
| Time to Breakeven | 939 days | 148 days |
| 2018 Correction | ||
| % Loss | -24.3% | -19.8% |
| % Gain to Breakeven | 32.2% | 24.7% |
| Time to Breakeven | 260 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -75.7% | -56.8% |
| % Gain to Breakeven | 312.2% | 131.3% |
| Time to Breakeven | 1,064 days | 1,480 days |
Compare to AFL, CNO, UNM, PRI, LNC
In The Past
Globe Life's stock fell -19.9% during the 2022 Inflation Shock from a high on 6/4/2021. A -19.9% loss requires a 24.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Globe Life (GL)
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
AI Analysis | Feedback
Here are 1-2 brief analogies for Globe Life (GL):
- Like Aflac, but for life insurance and supplemental health coverage, often targeting specific groups through agents.
- A State Farm or Farmers Insurance, but exclusively focused on life and supplemental health policies sold through agents.
AI Analysis | Feedback
- Life Insurance: Offers various policies, including term and whole life insurance, providing financial protection to beneficiaries upon the policyholder's death.
- Supplemental Health Insurance: Provides additional financial benefits for specific health events such as accidents, critical illnesses, or hospital stays.
AI Analysis | Feedback
Globe Life (symbol: GL) primarily sells insurance policies to individuals rather than to other companies. Its business model focuses on direct marketing to consumers and working with specific affinity groups to offer voluntary benefits to their members.
The company serves the following categories of customers:
- Individuals and Families: These customers directly purchase life, accident, and supplemental health insurance policies for themselves and their dependents. This includes a broad demographic seeking various forms of personal protection and financial security.
- Members of Labor Unions, Credit Unions, and Associations: Through its subsidiary American Income Life (AIL) and other channels, Globe Life partners with various organizations. It then offers voluntary supplemental insurance products (e.g., life, accident, critical illness) directly to the individual members of these unions, credit unions, and other associations.
- Individuals Seeking Supplemental Health Coverage: This category encompasses individuals looking for specific health-related insurance products that complement their primary health insurance or Medicare. This includes policies for critical illness, cancer, accidental injury, and hospital indemnity, often targeting individuals concerned about out-of-pocket medical expenses.
AI Analysis | Feedback
null
AI Analysis | Feedback
```htmlFrank M. Svoboda Co-Chairman and Chief Executive Officer
- Mr. Svoboda has served as Co-Chairman and Co-Chief Executive Officer of Globe Life Inc. since January 2023. Previously, he held the positions of Chief Financial Officer and Senior Executive Vice President of the company. He also served as President of the subsidiary American Income Life Insurance Company from 2017 to 2018. With over 35 years of insurance industry experience, his background includes finance, accounting, tax, mergers and acquisitions, and capital market transactions. Prior to joining Globe Life in 2003, Mr. Svoboda was a Partner in Insurance Tax at KPMG US from May 1984 to May 2003, where he oversaw services for life, health, and property/casualty clients in the Southwest Area.
J. Matthew Darden Co-Chairman and Chief Executive Officer
- Mr. Darden has been Co-Chairman and Co-Chief Executive Officer of Globe Life Inc. since January 2023. Before this role, he was the Senior Executive Vice President and Chief Strategy Officer for the company. He also served as President of American Income Life since 2018 and as Executive Vice President of Innovations and Business Development from October 2014 to December 2016. Mr. Darden brings 28 years of insurance industry experience in areas such as marketing, sales, administration, finance, accounting, information technology, business combinations, and capital market transactions. Prior to his tenure at Globe Life, which began in 2014, he was a Partner with Deloitte & Touche LLP.
Thomas P. Kalmbach Executive Vice President and Chief Financial Officer
- Mr. Kalmbach assumed the role of Executive Vice President and Chief Financial Officer of Globe Life Inc. in January 2023. He also serves as President of Globe and President of Family Heritage within the company. From January 2019 to December 2022, he was the Chief Actuary and Executive Vice President, and from August 2018 to December 2022, he held the position of Senior Vice President and Chief Actuary for American Income, Globe, Liberty, and United American. His prior experience includes various actuarial and financial roles at different insurance companies, including serving as Chief Financial Officer with Liberty Life Insurance of Boston.
Michael C. Majors Executive Vice President and Chief Strategy Officer
- Mr. Majors has served as Chief Strategy Officer and Executive Vice President of Policy Acquisition for Globe Life Inc. since January 2023. Additionally, he has been the President of United American since March 2015. Prior to these roles, he was the Executive Vice President of Administration and Investor Relations for the company from July 2018 to December 2022.
R. Brian Mitchell Executive Vice President, General Counsel and Chief Risk Officer
- Mr. Mitchell serves as the Executive Vice President, General Counsel, and Chief Risk Officer for Globe Life Inc.
AI Analysis | Feedback
The key risks to Globe Life's business include:
- Regulatory Scrutiny, Legal Actions, and Reputational Damage: Globe Life is facing significant challenges due to allegations of widespread insurance fraud, including issuing policies for deceased or fictitious individuals, forging signatures, and unauthorized withdrawals from customer accounts. These allegations have led to a Department of Justice (DOJ) probe into its American Income Life (AIL) subsidiary's business practices and sales tactics, as well as securities class action lawsuits filed against the company. There are also claims of a hostile workplace, sexual harassment, and drug use within AIL. These issues have resulted in expanded risk disclosures in recent financial reports and increased legal costs, significantly impacting the company's reputation and potentially its operational integrity. Furthermore, the Direct Selling Self-Regulatory Council (DSSRC) has raised concerns about misleading marketing claims, referring the matter to federal authorities.
- Investment Portfolio Subject to Market and Credit Risks: A substantial portion of Globe Life's investment portfolio, 88% of its carrying value, is comprised of fixed-maturity investments, making it highly susceptible to interest rate risk. Fluctuations in interest rates can significantly affect net investment income and capital ratios, and a prolonged period of elevated interest rates could suppress the company's valuation. While the company generally intends to hold these securities until maturity to mitigate unrealized losses, adverse market conditions or credit downgrades could still impact its financial position and liquidity.
- Intense Competition and Operational Challenges: The insurance industry is highly competitive, with numerous players vying for market share against Globe Life's direct-to-consumer model. The company faces operational pressures such as policy acquisition cost growth outpacing premium growth, rising lapse rates, and slowed growth in its agent count. Additionally, profitability in its health segment has been pressured by increased utilization rates, and the company must contend with competitive threats from insurtech companies offering superior digital customer experiences. Challenges related to misleading marketing, customer service, and product design also pose risks to attracting and retaining policyholders.
AI Analysis | Feedback
The clear emerging threat to Globe Life (GL) is the rapid growth and increasing market penetration of **direct-to-consumer (DTC) digital insurance platforms (Insurtechs)**.
These companies, such as Ethos, Bestow, and Haven Life (a MassMutual subsidiary), leverage technology to offer fully online, streamlined applications for life insurance and, increasingly, supplemental health products. They employ simplified underwriting processes, often utilizing AI and data analytics, to provide quick quotes and policy issuance without the need for traditional agents or extensive paperwork.
This directly threatens Globe Life's business model, which heavily relies on its traditional agency sales force and direct mail marketing to reach its target demographic. While Globe Life has a strong presence in the middle-income and underserved markets, these digital-first competitors:
- **Bypass traditional distribution channels:** They eliminate the need for agents, offering a self-service model that appeals to a growing segment of consumers, particularly younger demographics, who prefer digital convenience, transparency, and speed.
- **Offer competitive pricing and efficiency:** By reducing overhead associated with agent commissions and traditional marketing, some insurtechs can offer more competitive pricing or reallocate savings to enhance customer experience.
- **Cater to evolving consumer preferences:** A significant portion of consumers now expect digital, on-demand services for financial products. Globe Life's more traditional sales process can appear slower and less convenient by comparison.
This dynamic is analogous to Netflix disrupting Blockbuster's physical store model, where a more convenient and digitally-driven distribution method directly challenges and erodes the market share of a legacy operator.
AI Analysis | Feedback
Globe Life (NYSE: GL) operates primarily in the United States, offering a range of life and supplemental health insurance products. The addressable markets for its main products and services in the U.S. are substantial.
Life Insurance Market (U.S.)
The U.S. life insurance market, which includes products such as whole life, term life, children's life, final expense, accidental death, and mortgage protection insurance, was estimated at approximately USD 1.93 trillion in 2024. This market is projected to grow to around USD 4.74 trillion by 2034, demonstrating a Compound Annual Growth Rate (CAGR) of 9.40% from 2025 to 2034.
Supplemental Health Insurance Market (U.S.)
Globe Life provides various supplemental health insurance products, including accident, cancer, critical illness, ICU, and hospital insurance. The U.S. supplemental health insurance market was valued at an estimated USD 38.58 billion in 2024. It is forecasted to increase to approximately USD 66.45 billion by 2034, with a CAGR of 5.60% from 2025 to 2034.
Medicare Supplement Health Insurance Market (U.S.)
Medicare Supplement insurance is another key offering by Globe Life. The U.S. Medicare Supplement health insurance market was valued at approximately USD 27.15 billion in 2023 and is projected to reach around USD 44.65 billion by 2033, growing at a CAGR of 5.10% during the forecast period of 2024 to 2033.
Accident Insurance Market (U.S.)
Specifically within supplemental health, the U.S. accident insurance market, which Globe Life offers, was valued at USD 23.94 billion in 2024. This market is expected to grow to USD 33.46 billion by 2032, exhibiting a CAGR of 4.33% over the forecast period of 2025-2032.
AI Analysis | Feedback
Expected Drivers of Future Revenue Growth for Globe Life (GL)
Over the next two to three years, Globe Life (GL) is expected to drive future revenue growth through several key initiatives and ongoing operational strengths. These drivers primarily focus on expanding its customer base and increasing premium generation across its distinct insurance divisions. 1. Growth in Exclusive Agent Count: Globe Life is actively expanding its exclusive agency force. The company reported over 17,500 exclusive agents as of Q3 2025 and has a strategic goal to surpass 28,000 agents by 2030, indicating a significant focus on increasing its sales capacity. An expanding agent force is a direct driver of new policy sales and, consequently, premium revenue growth. 2. Increased Life Premiums from American Income Life and Liberty National Divisions: The American Income Life and Liberty National Divisions have consistently shown growth in life premiums. In Q3 2025, life premiums in these divisions increased by 5% over the prior-year quarter, following a similar 5% increase in Q2 2025, suggesting sustained momentum in these segments. 3. Expansion of Health Net Sales and Premiums in the Family Heritage Division: The Family Heritage Division has demonstrated strong performance in its health insurance offerings. Health net sales for this division increased by 13% in Q3 2025, and health premiums grew by 10% over the year-ago quarter. Q2 2025 also saw robust growth with health net sales up 20% and health premiums up 9%. This indicates a continued focus and success in expanding the health insurance portfolio. 4. Growth in Direct to Consumer Life Net Sales: The Direct to Consumer Division has shown positive trends in its life net sales. After experiencing its first positive sales trend in 16 quarters in Q2 2025, with a 2% increase over the prior year and a 24% increase over Q1 2025, this division continued its positive trajectory with a 13% increase in life net sales in Q3 2025. This suggests a revitalized and growing channel for new customer acquisition. 5. Overall Premium Revenue Growth: Analysts generally forecast continued premium revenue growth for Globe Life. For the full year 2025, total premium revenue growth is expected to be around 5%. While specific long-term forward guidance for total premium growth was not explicitly detailed beyond 2025 in the provided snippets, the consistent growth in key divisions and agent expansion efforts underpin expectations for continued overall premium revenue increases.AI Analysis | Feedback
Share Repurchases
- Globe Life's Board of Directors authorized a new share repurchase program of up to $1.8 billion in November 2024, replacing a $1.3 billion authorization from April 2024.
- The company repurchased 10.1 million shares at a total cost of $946 million during 2024.
- In 2023, Globe Life repurchased 3.4 million shares at a total cost of $380 million, following approximately $454.6 million in repurchases during 2022.
Share Issuance
- Globe Life has not reported significant share issuances (primary offerings) over the last 3-5 years; instead, the number of outstanding shares has decreased due to ongoing share repurchase programs.
Capital Expenditures
- Capital expenditures for Globe Life were $71.05 million in 2024, $49.55 million in 2023, and $27.93 million in 2022.
- Prior year capital expenditures included $38.24 million in 2021 and $41.76 million in 2020.
Latest Trefis Analyses
Trade Ideas
Select ideas related to GL.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | NDAQ | Nasdaq | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | JEF | Jefferies Financial | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | PAYO | Payoneer Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02272026 | FOUR | Shift4 Payments | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02202026 | COIN | Coinbase Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 2.6% | 2.6% | -6.5% |
| 05312024 | GL | Globe Life | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 35.1% | 48.6% | -5.9% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 92.73 |
| Mkt Cap | 10.0 |
| Rev LTM | 9,491 |
| Op Inc LTM | - |
| FCF LTM | 745 |
| FCF 3Y Avg | 875 |
| CFO LTM | 761 |
| CFO 3Y Avg | 955 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.5% |
| Rev Chg 3Y Avg | 5.1% |
| Rev Chg Q | 3.9% |
| QoQ Delta Rev Chg LTM | 1.0% |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | 14.7% |
| CFO/Rev 3Y Avg | 15.6% |
| FCF/Rev LTM | 14.7% |
| FCF/Rev 3Y Avg | 15.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 10.0 |
| P/S | 1.4 |
| P/EBIT | 8.6 |
| P/E | 13.0 |
| P/CFO | 9.2 |
| Total Yield | 9.5% |
| Dividend Yield | 1.8% |
| FCF Yield 3Y Avg | 9.0% |
| D/E | 0.3 |
| Net D/E | -1.2 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -0.1% |
| 3M Rtn | 2.6% |
| 6M Rtn | 4.7% |
| 12M Rtn | -1.7% |
| 3Y Rtn | 57.7% |
| 1M Excs Rtn | 1.6% |
| 3M Excs Rtn | 0.8% |
| 6M Excs Rtn | -0.9% |
| 12M Excs Rtn | -17.3% |
| 3Y Excs Rtn | -1.6% |
Price Behavior
Price Behavior
| Market Price | $146.33 | |
| Market Cap ($ Bil) | 11.6 | |
| First Trading Date | 12/30/1987 | |
| Distance from 52W High | -0.4% | |
| 50 Days | 200 Days | |
| DMA Price | $141.74 | $134.11 |
| DMA Trend | up | up |
| Distance from DMA | 3.2% | 9.1% |
| 3M | 1YR | |
| Volatility | 18.0% | 25.6% |
| Downside Capture | -29.60 | 47.28 |
| Upside Capture | 37.03 | 54.65 |
| Correlation (SPY) | 15.8% | 55.5% |
GL Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.20 | 0.12 | 0.27 | 0.26 | 0.74 | 0.61 |
| Up Beta | -0.12 | 0.55 | 0.40 | 0.80 | 0.80 | 0.77 |
| Down Beta | 0.42 | 0.67 | 0.62 | 0.32 | 0.94 | 0.73 |
| Up Capture | -10% | -16% | 31% | 12% | 43% | 13% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 15 | 23 | 34 | 65 | 138 | 420 |
| Down Capture | -78% | -43% | -19% | 5% | 57% | 65% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 6 | 18 | 26 | 57 | 111 | 329 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GL | |
|---|---|---|---|---|
| GL | 18.9% | 25.6% | 0.64 | - |
| Sector ETF (XLF) | 1.4% | 19.8% | -0.04 | 68.2% |
| Equity (SPY) | 18.4% | 19.3% | 0.75 | 55.4% |
| Gold (GLD) | 86.5% | 25.7% | 2.41 | -1.5% |
| Commodities (DBC) | 16.5% | 17.1% | 0.73 | 12.2% |
| Real Estate (VNQ) | 7.1% | 16.6% | 0.24 | 58.3% |
| Bitcoin (BTCUSD) | -22.3% | 45.0% | -0.43 | 13.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GL | |
|---|---|---|---|---|
| GL | 9.7% | 35.8% | 0.39 | - |
| Sector ETF (XLF) | 11.1% | 18.8% | 0.47 | 46.0% |
| Equity (SPY) | 13.6% | 17.0% | 0.63 | 31.9% |
| Gold (GLD) | 23.9% | 17.2% | 1.14 | -3.2% |
| Commodities (DBC) | 11.1% | 19.0% | 0.47 | 8.9% |
| Real Estate (VNQ) | 5.1% | 18.8% | 0.17 | 27.5% |
| Bitcoin (BTCUSD) | 6.2% | 56.8% | 0.33 | 8.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with GL | |
|---|---|---|---|---|
| GL | 11.7% | 32.1% | 0.45 | - |
| Sector ETF (XLF) | 13.6% | 22.2% | 0.56 | 65.6% |
| Equity (SPY) | 15.3% | 17.9% | 0.73 | 53.3% |
| Gold (GLD) | 15.6% | 15.6% | 0.84 | -5.0% |
| Commodities (DBC) | 8.9% | 17.6% | 0.42 | 19.5% |
| Real Estate (VNQ) | 6.5% | 20.7% | 0.28 | 45.9% |
| Bitcoin (BTCUSD) | 65.1% | 66.8% | 1.05 | 10.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/4/2026 | |||
| 10/22/2025 | 0.1% | -2.9% | -3.9% |
| 7/23/2025 | 5.4% | 13.0% | 11.9% |
| 4/30/2025 | -4.6% | -1.9% | -1.2% |
| 2/5/2025 | -2.5% | -1.3% | 2.0% |
| 10/23/2024 | -1.3% | -3.5% | -1.7% |
| 7/24/2024 | 0.9% | 5.1% | 12.1% |
| 4/22/2024 | 14.1% | 17.6% | 25.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 12 | 14 |
| # Negative | 13 | 12 | 10 |
| Median Positive | 2.0% | 3.1% | 2.3% |
| Median Negative | -2.1% | -2.6% | -3.1% |
| Max Positive | 14.1% | 17.6% | 25.5% |
| Max Negative | -5.2% | -7.7% | -16.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/25/2026 | 10-K |
| 09/30/2025 | 11/05/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 02/26/2025 | 10-K |
| 09/30/2024 | 11/06/2024 | 10-Q |
| 06/30/2024 | 08/07/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 02/28/2024 | 10-K |
| 09/30/2023 | 11/06/2023 | 10-Q |
| 06/30/2023 | 08/08/2023 | 10-Q |
| 03/31/2023 | 05/09/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/05/2022 | 10-Q |
| 03/31/2022 | 05/06/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Svoboda, Frank M | Co-Chairman & CEO | Direct | Sell | 12172025 | 140.43 | 9,379 | 1,317,072 | 5,036,864 | Form |
| 2 | Henrie, Michael Shane | SVP & Chief Accounting Officer | Direct | Sell | 12152025 | 139.10 | 3,065 | 426,341 | 422,863 | Form |
| 3 | Mitchell, Robert Brian | EVP, General Counsel and CRO | Direct | Sell | 10272025 | 134.28 | 91,000 | 12,219,026 | 1,084,136 | Form |
| 4 | Skarjune, Dolores L | EVP and Chief Admin. Officer | Direct | Sell | 9152025 | 142.52 | 4,500 | 641,340 | 1,342,111 | Form |
| 5 | Skarjune, Dolores L | EVP and Chief Admin. Officer | Direct | Sell | 9112025 | 139.83 | 4,974 | 695,537 | 1,316,821 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Life & Health Insurance Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.